Neuroone Medical Technologies (NMTC) Operating Income Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59% |
| Dec 31, 2025 | 4.45% |
| Sep 30, 2025 | -63.48% |
| Jun 30, 2025 | -3.43% |
| Mar 31, 2025 | -14.24% |
| Dec 31, 2024 | 24.10% |
| Sep 30, 2024 | -15.79% |
| Jun 30, 2024 | -8.44% |
| Mar 31, 2024 | -13.67% |
| Jun 30, 2023 | -24.53% |
| Mar 31, 2023 | -26.08% |
| Dec 31, 2022 | -18.19% |
| Sep 30, 2022 | -9.39% |
| Jun 30, 2022 | -25.45% |
| Mar 31, 2022 | -42.76% |
| Dec 31, 2021 | -72.74% |
| Sep 30, 2021 | -214.45% |
| Jun 30, 2021 | -192.78% |
| Mar 31, 2021 | -252.75% |
| Dec 31, 2020 | -199.95% |
| Sep 30, 2020 | -114.45% |
| Jun 30, 2020 | -143.36% |
| Mar 31, 2020 | -276.15% |
| Jun 30, 2019 | -158.89% |
| Mar 31, 2019 | -229.81% |
| Jun 30, 2018 | -139.76% |
| Mar 31, 2018 | -225.90% |
| Dec 31, 2017 | -255.28% |
| Sep 30, 2017 | -185.27% |
| Jun 30, 2017 | -229.56% |
| Mar 31, 2017 | -147.84% |
| Dec 31, 2016 | -63.87% |
| Sep 30, 2016 | -15.82% |
| Jun 30, 2016 | -64.20% |
| Mar 31, 2016 | 8.02% |